Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 15/20 | 0.62 |
| ▸ | MMP9 | P14780 | 15/20 | 0.62 |
| ▸ | ADAM17 | P78536 | 4/20 | 0.62 |
| ▸ | MMP1 | P03956 | 4/20 | 0.62 |
| ▸ | MMP14 | P50281 | 4/20 | 0.62 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.59 |
| ▸ | MMP13 | P45452 | 5/20 | 0.55 |
| ▸ | MMP3 | P08254 | 3/20 | 0.55 |
| ▸ | ADAMTS4 | O75173 | 2/20 | 0.49 |
| ▸ | MMP8 | P22894 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7956126 | 0.94 | MMP2 (0.55) | MMP2MMP9ADAM17MMP1MMP14 | |
| SCHEMBL6722459 | 0.93 | MMP2 (0.57) | MMP2MMP9ADAM17MMP1MMP14 | |
| SCHEMBL6722448 | 0.90 | MMP2 (0.64) | MMP2MMP9ADAM17MMP1MMP14 | |
| SCHEMBL6723629 | 0.88 | MMP2 (0.56) | MMP2MMP9ADAM17MMP1MMP14 | |
| SCHEMBL7945731 | 0.88 | MMP2 (0.57) | MMP2MMP9ADAM17MMP1MMP14 | |
| SCHEMBL6719056 | 0.87 | MMP9 (0.66) | MMP2MMP9ADAM17MMP1MMP14 | |
| SCHEMBL7956109 | 0.87 | MMP2 (0.51) | MMP2MMP9ADAM17MMP1MMP14 | |
| SCHEMBL6719666 | 0.86 | MMP2 (0.54) | MMP2MMP9ADAM17MMP1MMP14 | |
| SCHEMBL7954530 | 0.83 | MMP2 (0.68) | MMP2MMP9ADAM17MMP1MMP14 | |
| SCHEMBL7956055 | 0.82 | MMP2 (0.57) | MMP2MMP9ADAM17MMP1MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6673804-B1 | PREVENTING OR TREATING ARTHRITIS (PARTICULARLY OSTEOARTHRITIS) OR INHIBITING METASTASIS, INVASION OR GROWTH OF CANCER (PARTICULARLY BREAST CANCER) | SANKYO COMPANY, LIMITED (JP) | 2004-01-06 | — | — | US | disclosed |
| EP-1069110-A1 | SULFONAMIDE DERIVATIVES | Sankyo Company Limited (JP) | 2001-01-17 | — | — | EP | disclosed |